Trials / Completed
CompletedNCT05608616
Maternal and Fetal Outcomes in Pregnant Women With COVID -19,a Cross Sectional Study
COVID-19 and Pregnancy Maternal and Fetal Outcomes,A Retrospective Cross Sectional Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 70 (actual)
- Sponsor
- Cairo University · Academic / Other
- Sex
- Female
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The spread of a new coronavirus (SARS-CoV-2) from Wuhan, China, has been fast, and the World Health Organization (WHO) declared a pandemic on March 11th, 2020 .It has now spread worldwide and is one of the most severe public health threats.The clinical characteristics of COVID-19 and the likelihood of transmission vertically or during delivery in pregnant women are still unknown.
Detailed description
In this cross sectional study,the following questions require immediate attention: whether COVID-19 symptoms in pregnant women differ from symptoms in non-pregnant women; whether disease complications and mortality rates are higher in pregnant women than in non-pregnant women; and whether there is a risk of premature delivery, foetal mortality, or even vertical transmission of the disease. These questions must be answered in order to plan optimal obstetrical management for pregnant women with COVID-19
Conditions
Timeline
- Start date
- 2022-04-01
- Primary completion
- 2022-09-01
- Completion
- 2022-10-01
- First posted
- 2022-11-08
- Last updated
- 2022-11-08
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT05608616. Inclusion in this directory is not an endorsement.